These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20038829)

  • 1. Enhanced anticancer effect of gemcitabine by genistein in osteosarcoma: the role of Akt and nuclear factor-kappaB.
    Zhang B; Shi ZL; Liu B; Yan XB; Feng J; Tao HM
    Anticancer Drugs; 2010 Mar; 21(3):288-96. PubMed ID: 20038829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein potentiates the anti-cancer effects of gemcitabine in human osteosarcoma via the downregulation of Akt and nuclear factor-κB pathway.
    Liang C; Li H; Shen C; Lai J; Shi Z; Liu B; Tao HM
    Anticancer Agents Med Chem; 2012 Jun; 12(5):554-63. PubMed ID: 22263786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Licoricidin enhances gemcitabine-induced cytotoxicity in osteosarcoma cells by suppressing the Akt and NF-κB signal pathways.
    Wang Y; Wang S; Liu J; Lu Y; Li D
    Chem Biol Interact; 2018 Jun; 290():44-51. PubMed ID: 29782821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
    Banerjee S; Zhang Y; Ali S; Bhuiyan M; Wang Z; Chiao PJ; Philip PA; Abbruzzese J; Sarkar FH
    Cancer Res; 2005 Oct; 65(19):9064-72. PubMed ID: 16204081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB.
    El-Rayes BF; Ali S; Ali IF; Philip PA; Abbruzzese J; Sarkar FH
    Cancer Res; 2006 Nov; 66(21):10553-9. PubMed ID: 17079479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.
    Arlt A; Gehrz A; Müerköster S; Vorndamm J; Kruse ML; Fölsch UR; Schäfer H
    Oncogene; 2003 May; 22(21):3243-51. PubMed ID: 12761494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.
    Chen D; Niu M; Jiao X; Zhang K; Liang J; Zhang D
    Int J Mol Sci; 2012; 13(1):1186-1208. PubMed ID: 22312312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells.
    Jeon HG; Yoon CY; Yu JH; Park MJ; Lee JE; Jeong SJ; Hong SK; Byun SS; Lee SE
    J Urol; 2011 Nov; 186(5):2084-93. PubMed ID: 21944112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines.
    Gadgeel SM; Ali S; Philip PA; Wozniak A; Sarkar FH
    Cancer; 2009 May; 115(10):2165-76. PubMed ID: 19288574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer.
    Ahn DW; Seo JK; Lee SH; Hwang JH; Lee JK; Ryu JK; Kim YT; Yoon YB
    Pancreas; 2012 Oct; 41(7):1048-57. PubMed ID: 22513291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
    McMahon MB; Bear MD; Kulp SK; Pennell ML; London CA
    Am J Vet Res; 2010 Jul; 71(7):799-808. PubMed ID: 20594083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer.
    Lee SH; Ryu JK; Lee KY; Woo SM; Park JK; Yoo JW; Kim YT; Yoon YB
    Cancer Lett; 2008 Jan; 259(1):39-49. PubMed ID: 17967505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
    Waters JA; Matos J; Yip-Schneider M; Aguilar-Saavedra JR; Crean CD; Beane JD; Dumas RP; Suvannasankha A; Schmidt CM
    Surgery; 2015 Oct; 158(4):881-8; discussion 888-9. PubMed ID: 26209568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propofol induces apoptosis and increases gemcitabine sensitivity in pancreatic cancer cells in vitro by inhibition of nuclear factor-κB activity.
    Du QH; Xu YB; Zhang MY; Yun P; He CY
    World J Gastroenterol; 2013 Sep; 19(33):5485-92. PubMed ID: 24023491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer.
    Banerjee S; Zhang Y; Wang Z; Che M; Chiao PJ; Abbruzzese JL; Sarkar FH
    Int J Cancer; 2007 Feb; 120(4):906-17. PubMed ID: 17131310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB; Guha S; Krishnan S; Diagaradjane P; Gelovani J; Aggarwal BB
    Cancer Res; 2007 Apr; 67(8):3853-61. PubMed ID: 17440100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway.
    Sun ZY; Jian YK; Zhu HY; Li B
    Pathol Res Pract; 2019 Mar; 215(3):555-563. PubMed ID: 30661902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer.
    Bao GQ; Shen BY; Pan CP; Zhang YJ; Shi MM; Peng CH
    Toxicol Lett; 2013 Sep; 222(1):23-35. PubMed ID: 23845849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irisin Enhances Doxorubicin-Induced Cell Apoptosis in Pancreatic Cancer by Inhibiting the PI3K/AKT/NF-κB Pathway.
    Liu J; Huang Y; Liu Y; Chen Y
    Med Sci Monit; 2019 Aug; 25():6085-6096. PubMed ID: 31412018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
    Wei WT; Chen H; Ni ZL; Liu HB; Tong HF; Fan L; Liu A; Qiu MX; Liu DL; Guo HC; Wang ZH; Lin SZ
    Int J Oncol; 2011 Dec; 39(6):1381-90. PubMed ID: 21805032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.